PRKCA and breast cancer: Indeed, Llorens et al. (2019) recently unveiled the molecular mechanisms by which PKC-α modulates epithelial-to-mesenchymal transition (EMT) and the invasiveness of breast cancer cells through regulation of ZEB1 expression.